Search Results

Guangzhou Panyu Central Hospital Researchers Release New Data on Rheumatic Diseases and Conditions (Research progress on the clinical application and mechanism of iguratimod in the treatment of autoimmune diseases and rheumatic diseases)

• Source: Obesity, Fitness & Wellness Week. October 14, 2023, 2427

Record details

A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting

• Authors : Rood, J.W.; du Toit, R.

• Source: SAMJ South African Medical Journal. December, 2020, Vol. 110 Issue 12, p1231, 7 p.

Record details

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases

• Authors : Kingsmore, Kathryn M.; Grammer, Amrie C.; Lipsky, Peter E.

• Source: Nature Reviews Rheumatology. January, 2020, Vol. 16 Issue 1, p32, 21 p.

Record details

Prescription analysis of rheumatology and endocrinology departments of a teaching hospital in Western India

• Authors : Yadav, Vikas; Jaiswal, Sanjay; Shyam, Sharan

• Source: Journal of Current Research in Scientific Medicine. July-Dec, 2022, Vol. 8 Issue 2, 168

Record details

Findings from Brigham and Women's Hospital Broaden Understanding of Antirheumatics (Genetics Are Not Likely To Offer Clinically Useful Predictions for Elevated Liver Enzyme Levels In Patients Using Low Dose Methotrexate)

• Source: Obesity, Fitness & Wellness Week. December 3, 2022, 811

Record details

New Rheumatoid Arthritis Study Findings Recently Were Reported by Researchers at Department of Rheumatology [Effectiveness and Safety of Original and Biosimilar Etanercept (Enbrel ® Vs Benepali ®) In Bdmard-naive Patients In a Real-world ...]

• Source: Obesity, Fitness & Wellness Week. August 13, 2022, 3736

Record details

Study Data from University of Tunis El Manar Provide New Insights into Rheumatic Diseases and Conditions (Adherence To Biologic Disease-modifying Antirheumatic Drugs In Adult Patients With Rheumatic Diseases)

• Source: Obesity, Fitness & Wellness Week. April 30, 2022, 863

Record details

The emerging safety profile of JAK inhibitors in rheumatic disease

• Authors : Winthrop, Kevin L.

• Source: Nature Reviews Rheumatology. April, 2017, Vol. 13 Issue 4, p234, 10 p.

Record details

Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products

• Authors : Gonzalez, Carlos M.; Carmona, Loreto; Toro, Javier de

• Source: Patient Preference and Adherence. Annual, 2017, Vol. 11, p1243, 9 p.

Record details

Persistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis

• Authors : Svedbom, Axel; Storck, Chiara; Kachroo, Sumesh

• Source: Patient Preference and Adherence. Annual, 2017, Vol. 11, p719, 11 p.

Record details